Mahamaya Lifesciences IPO

Incorporated in 2002, Mahamaya Lifesciences Limited manufactures, registers, and exports crop protection products and bioproducts that enhance crop and soil health. The company specialises in pesticide formulations and supplies bulk products to leading Indian agrochemical companies and multinational corporations. Its international presence spans the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey.

Mahamaya Lifesciences Limited IPO Overview

Mahamaya Lifesciences Limited is launching its IPO through a book-built issue worth ₹70.44 crore. The issue comprises a fresh offering of 0.56 crore shares, aggregating to ₹64.28 crore, along with an offer for sale of 0.05 crore shares, amounting to ₹6.16 crore. The IPO will open for subscription on 11 November 2025 and close on 13 November 2025, with the allotment expected to be finalised on 14 November 2025. The company’s shares are proposed to be listed on the BSE SME platform, with a tentative listing date set for 18 November 2025.

The price band for the Mahamaya Lifesciences IPO is fixed between ₹108 and ₹114 per share, and the lot size is 1,200 shares. Retail investors can apply for a minimum of two lots (2,400 shares) requiring an investment of ₹2,73,600 at the upper price band, while the minimum application for HNI investors is three lots (3,600 shares), amounting to ₹4,10,400.

Oneview Corporate Advisors Pvt. Ltd. is the Book Running Lead Manager of the issue, while Kfin Technologies Ltd. serves as the Registrar. The Market Maker for the IPO is Mansi Share & Stock Broking Pvt. Ltd.

Mahamaya Lifesciences Limited IPO Details

Particulars	Details
IPO Date	11 November 2025 to 13 November 2025
Listing Date	18 November 2025
Face Value	₹10 per share
Issue Price Band	₹108 to ₹114 per share
Lot Size	1,200 Shares
Total Issue Size	61,78,800 shares (aggregating up to ₹70.44 Cr)
Fresh Issue	56,38,800 shares (aggregating up to ₹64.28 Cr)
Offer for Sale	5,40,000 shares (aggregating up to ₹6.16 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE SME
Share Holding Pre Issue	1,77,66,200 shares
Share Holding Post Issue	2,34,05,000 shares
Market Maker Portion	3,09,600 shares (aggregating up to ₹3.53 Cr)

Mahamaya Lifesciences Limited IPO Reservation

Investor Category	Shares Offered
QIB	Not more than 50% of the Net Offer
Retail	Not less than 35% of the Net Offer
NII (HNI)	Not more than 15% of the Net Offer

Mahamaya Lifesciences Limited IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	2	2,400	₹2,73,600
Retail (Max)	2	2,400	₹2,73,600
S-HNI (Min)	3	3,600	₹4,10,400
S-HNI (Max)	7	8,400	₹9,57,600
B-HNI (Min)	8	9,600	₹10,94,400

Mahamaya Lifesciences Limited IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	77.27%
Post-Issue	56.35%

Mahamaya Lifesciences Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	₹7.29
Price/Earnings (P/E) Ratio	15.65 (Pre-Issue), 16.25 (Post-Issue)
Return on Net Worth (RoNW)	26.19%
Net Asset Value (NAV)	₹27.82
Return on Equity (ROE)	34.94%
Return on Capital Employed (ROCE)	23.15%
EBITDA Margin	9.22%
PAT Margin	4.84%
Debt to Equity Ratio	1.08

Objectives of the Proceeds

• Purchase of equipment for existing formulation plant – ₹3.75 crore

• Funding capital expenditure for new technical manufacturing plant – ₹29.42 crore

• Construction of warehouse building and purchase of machinery – ₹2.53 crore

• Funding working capital requirement – ₹18.00 crore

• General corporate purposes – balance amount

Key Financials (in ₹ crore)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	188.35	112.07	77.88
Revenue	267.17	162.83	137.40
Profit After Tax	12.94	5.22	3.75
Reserves and Surplus	31.66	23.41	18.19
Total Borrowings	58.11	54.63	24.37